Home » Healthcare » Clinical Trial Recruitment in Respiratory Market

Clinical Trial Recruitment in Respiratory Market By Service Type (Patient Recruitment & Registry Services, Patient Retention Services, Others) By Phase (Phase I, Phase II, Phase III, Phase IV) By Age Group (Child (Birth-17 Years), Adult (18 – 64 Years), Older Adults (65 Years+) – Growth, Future Prospects & Competitive Analysis, 2016 – 2028

Price: $4999

Published: | Report ID: 3158 | Report Format : PDF

About this report

The global clinical trial recruitment in respiratory market report explores the critical analysis of the clinical trial recruitment in respiratory industry using the key parameters. The report consists of investment strategies, the need for investments in the clinical trial recruitment in respiratory industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the clinical trial recruitment in respiratory industry and how economic and non-economic barriers are helping the clinical trial recruitment in respiratory market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

 

Key Highlights of the report

How are the major segments performing in the clinical trial recruitment in respiratory market?

  • In 2021, the patient recruitment & registry services held the highest revenue share in clinical trial recruitment in respiratory market. The growth is majorly due to the rising adoption of digital technologies in enrolment services.
  • In 2021, phase III category dominated the market with significant revenue share in the market. This growth can be ascribed to the fact that phase III clinical studies are the costliest and include a large number of patients.
  • In 2021, adult (18 – 64 Years) category held the highest market share of global clinical trial recruitment in respiratory market. The growth is majorly due to the participation of a higher number of participants in clinical studies as well as the age group is seeing an increase in the prevalence of health issues.

Which region dominated the clinical trial recruitment in respiratory market?

In 2021, North America led the global clinical trial recruitment in respiratory market due to the significant number of clinical trials being undertaken in the region. Furthermore, major R&D expenditures and government backing for clinical trials are driving the market growth over the forecast period.

What is the competitive environment of the clinical trial recruitment in respiratory market?

The clinical trial recruitment in respiratory industry’s competitive environment provides information on the entire economic profit made by suppliers and businesses, the sales and revenues created in this sector, the clinical trial recruitment in respiratory market share globally, the business organization summary, the introduction of new products, and the opportunities for the clinical trial recruitment in respiratory market. In addition, the primary expansion strategies of clinical trial organization for reaching out to consumers include a well-structured and efficient supply chain and an expanded hospitals network.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Why is patient recruitment important in clinical trials?

Recruitment and enrolment take a lot of time; therefore, they frequently cause trial deadlines to be missed. According to the National Center for Biotechnology Information, insufficient or late patient enrolment into randomised clinical trials has major repercussions. The trial length may need to be increased, which may increase resource utilisation and expenditures. Long trials delay the public’s access to potentially useful therapies. Adequate sample size is also required for the study’s integrity and validity. If the sample size is not met, the likelihood of making a type II mistake increases. The experiment may have to be cancelled, and the findings may not be published. Improving patient recruitment is one-way pharmaceutical firms might prevent such costly delays and shorten the time it takes for new treatments to reach the market. The medication development process comprises clinical studies that take place across four phases, each with a particular goal.

Which are the key investments by the clinical trial recruitment in respiratory market players?

Leading players operating in the clinical trial recruitment in respiratory market are focusing on expansion in production capacities for storage and retrieval systems. Apart from this, players are concentrating on strategic mergers and acquisitions, collaborations and creating awareness among the businesses via various advertisement campaigns to help the manufacturers to promote the usage of clinical trial recruitment in respiratory in the industry, which further helps to expand their customer base in global clinical trial recruitment in respiratory market to gain a competitive edge.

Some major players in the clinical trial recruitment in respiratory market are Antidote, Clara Health, Clariness, BBK Worldwide, Worldwide Clinical Trials, Clinical Site Services (CCSi), IQVIA, PPD Inc., Veristat, and Elligo Health Research.

What are the major driving factors for the clinical trial recruitment in respiratory market?

The growing incidence of clinical trials and the fast expansion of the medical and pharmaceutical sectors, are some major factors driving the growth of global clinical trial recruitment in respiratory market. Moreover, clinical trials are carried out to gather information on the efficacy and safety of new medical devices and drug development. As the number of individuals required for clinical trials grows due to regulatory and safety concerns, trends toward longer and larger studies emerge, boosting the demand for patient recruiting services in the market. Also, the biopharmaceutical industry’s change in attention to creating vaccines and medicines in response to COVID-19 has had unforeseen implications that may disrupt clinical trials for other illnesses. Such factors are responsible for fuelling the growth of clinical trial recruitment in respiratory market in the next few years.

What are the major risks for the clinical trial recruitment in respiratory market?

The high cost of conducting clinical trials and long approval times hinder market growth. Moreover, strict regulatory policies for patient enrolment and lack of expertise in clinical research, are some other factors which hampers the growth of global clinical trial recruitment in respiratory market.

Which is the key application in the clinical trial recruitment in respiratory market?

Patient retention services are expected to grow at significant CAGR over the forecast period. Technology is used for a variety of outreach strategies, including online health groups, social media, and digital marketing. These initiatives are quickly changing the clinical trial environment. Because these people are actively engaged online, sponsors, recruiting suppliers, advertising, and others may see behavioural trends. This is critical if organisations are employing online outreach to help with retention and want to know where to spend their money to reach the intended patient demographics.

How is the clinical trial recruitment in respiratory market performing in regions?

Asia-Pacific dominated with the highest revenue share in global Clinical Trial Recruitment in Respiratory market owing to the rising number of educational institutions in the emerging economies such as China and India. Furthermore, the growing investment by public and private organizations to encourage more student enrolment in schools further drives the market in this region. On the other hand, North America is expected to grow at a significant CAGR over the forecast period due to increasing consumer spending on child education across the region.

What is the regulatory landscape for the clinical trial recruitment in respiratory market?

Understanding the regulatory requirements for conducting, completing, and producing quality clinical trial data is critical before planning a clinical study. Distinct authorities have different standards, varying depending on the study type. Many researchers, for example, find patient recruitment in uncommon illnesses to be a nightmare, thus many regulators, such as the FDA, explore adaptive approaches in recruiting a few patients and extrapolating the safety findings. Guidelines for the design of clinical trials for small populations have been developed by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Regulators are willing to consider using various methodology and evidence sources to improve the overall evidence base.

What is the market size of clinical trial recruitment in respiratory regarding value?

The global clinical trial recruitment in respiratory market is anticipated to grow at a significant CAGR of XX% during the forecast period. The global clinical trial recruitment in respiratory industry was estimated to be worth USD XX billion in 2021 and was expected to be worth USD XX billion by 2028.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the clinical trial recruitment in respiratory market?

Growing regional existence and investment in downstream applications are anticipated to deliver a competitive edge in the market. For instance, in September 2021, Syneos Health collaborated with Ride Health, a provider of non-emergency medical transportation (NEMT) for clinical trial participants, to improve Syneos Health’s clinical trial recruiting and retention service by offering transportation facilities to participants.

Segmentation of Global Clinical Trial Recruitment in Respiratory Market-

Global Clinical Trial Recruitment in Respiratory Market – By Service Type

  • Patient Recruitment & Registry Services
  • Patient Retention Services
  • Others

Global Clinical Trial Recruitment in Respiratory Market – By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Clinical Trial Recruitment in Respiratory Market – By Age Group

  • Child (Birth-17 Years)
  • Adult (18 – 64 Years)
  • Older Adults (65 Years+)

Global Clinical Trial Recruitment in Respiratory Market – By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Clinical Trial Recruitment in Respiratory Market
2.2. Global Clinical Trial Recruitment in Respiratory Market, By Service Type
2.3. Global Clinical Trial Recruitment in Respiratory Market, By Phase
2.4. Global Clinical Trial Recruitment in Respiratory Market, By Age Group
2.5. Global Clinical Trial Recruitment in Respiratory Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Clinical Trial Recruitment in Respiratory Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Type
3.3.2. Application
3.3.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Service Type Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Clinical Trial Recruitment in Respiratory Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Clinical Trial Recruitment in Respiratory Market
7.1. Global Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Clinical Trial Recruitment in Respiratory Market, By Service Type, 2021 vs 2028 (in%)
7.1.3. Global Clinical Trial Recruitment in Respiratory Market, By Patient Recruitment & Registry Services, 2016-2028 (US$ Bn)
7.1.4. Global Clinical Trial Recruitment in Respiratory Market, By Patient Retention Services, 2016-2028 (US$ Bn)
7.1.5. Global Clinical Trial Recruitment in Respiratory Market, By Others, 2016-2028 (US$ Bn)
7.2. Global Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Clinical Trial Recruitment in Respiratory Market, By Phase, 2021 vs 2028 (in%)
7.2.3. Global Clinical Trial Recruitment in Respiratory Market, By Phase I, 2016-2028 (US$ Bn)
7.2.4. Global Clinical Trial Recruitment in Respiratory Market, By Phase II, 2016-2028 (US$ Bn)
7.2.5. Global Clinical Trial Recruitment in Respiratory Market, By Phase III, 2016-2028 (US$ Bn)
7.2.6. Global Clinical Trial Recruitment in Respiratory Market, By Phase IV, 2016-2028 (US$ Bn)
7.3. Global Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Clinical Trial Recruitment in Respiratory Market, By Age Group, 2021 vs 2028 (in%)
7.3.3. Global Clinical Trial Recruitment in Respiratory Market, By Child (Birth-17 Years), 2016-2028 (US$ Bn)
7.3.4. Global Clinical Trial Recruitment in Respiratory Market, By Adult (18 – 64 Years), 2016-2028 (US$ Bn)
7.3.5. Global Clinical Trial Recruitment in Respiratory Market, By Older Adults (65 Years+), 2016-2028 (US$ Bn)

8. North America Clinical Trial Recruitment in Respiratory Market Analysis
8.1. North America Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. U.S. Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
8.4.1.3. U.S. Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
8.4.1.4. U.S. Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. Canada Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
8.4.2.3. Canada Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
8.4.2.4. Canada Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)

9. Europe Clinical Trial Recruitment in Respiratory Market Analysis
9.1. Europe Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. Germany Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
9.4.1.3. Germany Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
9.4.1.4. Germany Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
9.4.2. France
9.4.2.1. France Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. France Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
9.4.2.3. France Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
9.4.2.4. France Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. UK Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
9.4.3.3. UK Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
9.4.3.4. UK Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. Italy Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
9.4.4.3. Italy Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
9.4.4.4. Italy Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. Spain Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
9.4.5.3. Spain Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
9.4.5.4. Spain Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Europe Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Europe Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
9.4.6.4. Rest of Europe Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)

10. Asia Pacific Clinical Trial Recruitment in Respiratory Market Analysis
10.1. Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
10.4.1. China
10.4.1.1. China Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. China Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
10.4.1.3. China Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
10.4.1.4. China Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Japan Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
10.4.2.3. Japan Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
10.4.2.4. Japan Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
10.4.3. India
10.4.3.1. India Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. India Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
10.4.3.3. India Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
10.4.3.4. India Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.4.2. South Korea Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
10.4.4.3. South Korea Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
10.4.4.4. South Korea Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.5.2. South-East Asia Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
10.4.5.3. South-East Asia Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
10.4.5.4. South-East Asia Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)

11. Latin America Clinical Trial Recruitment in Respiratory Market Analysis
11.1. Latin America Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. Brazil Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
11.4.1.3. Brazil Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
11.4.1.4. Brazil Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. Mexico Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
11.4.2.3. Mexico Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
11.4.2.4. Mexico Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Latin America Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Latin America Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Latin America Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)

12. Middle East and Africa Clinical Trial Recruitment in Respiratory Market Analysis
12.1. Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.1.2. GCC Countries Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
12.4.1.3. GCC Countries Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
12.4.1.4. GCC Countries Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.2.2. South Africa Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
12.4.2.3. South Africa Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
12.4.2.4. South Africa Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory, By Service Type, 2016-2028 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory, By Phase, 2016-2028 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory, By Age Group, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Antidote Technologies Inc.
13.1.1. Company Overview
13.1.2. Service Types/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Clara Health
13.3. Clariness
13.4. BBK Worldwide
13.5. Worldwide Clinical Trials
13.6. Clinical Site Services (CCSi)
13.7. IQVIA
13.8. PPD Inc.
13.9. Veristat
13.10. Elligo Health Research
13.11. Others

List of Figures

FIG. 1 Global Clinical Trial Recruitment in Respiratory Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Clinical Trial Recruitment in Respiratory Market Segmentation
FIG. 4 Global Clinical Trial Recruitment in Respiratory Market, by Service Type, 2021 (US$ Bn)
FIG. 5 Global Clinical Trial Recruitment in Respiratory Market, by Phase, 2021 (US$ Bn)
FIG. 6 Global Clinical Trial Recruitment in Respiratory Market, by Age Group, 2021 (US$ Bn)
FIG. 7 Global Clinical Trial Recruitment in Respiratory Market, by Geography, 2021 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Service Type, 2021
FIG. 9 Attractive Investment Proposition, by Phase, 2021
FIG. 10 Attractive Investment Proposition, by Age Group, 2021
FIG. 11 Attractive Investment Proposition, by Geography, 2021
FIG. 12 Global Market Share Analysis of Key Clinical Trial Recruitment in Respiratory Market Manufacturers, 2021
FIG. 13 Global Market Positioning of Key Clinical Trial Recruitment in Respiratory Market Manufacturers, 2021
FIG. 14 Global Clinical Trial Recruitment in Respiratory Market Value Contribution, By Service Type, 2021 & 2028 (Value %)
FIG. 15 Global Clinical Trial Recruitment in Respiratory Market, by Patient Recruitment & Registry Services, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Clinical Trial Recruitment in Respiratory Market, by Patient Retention Services, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Clinical Trial Recruitment in Respiratory Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Clinical Trial Recruitment in Respiratory Market Value Contribution, By Phase, 2021 & 2028 (Value %)
FIG. 19 Global Clinical Trial Recruitment in Respiratory Market, by Phase I, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Clinical Trial Recruitment in Respiratory Market, by Phase II, Value, 2016-2028 (US$ Bn)
FIG. 21 Global Clinical Trial Recruitment in Respiratory Market, by Phase III, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Clinical Trial Recruitment in Respiratory Market, by Phase IV, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Clinical Trial Recruitment in Respiratory Market Value Contribution, By Age Group, 2021 & 2028 (Value %)
FIG. 24 Global Clinical Trial Recruitment in Respiratory Market, by Child (Birth-17 Years), Value, 2016-2028 (US$ Bn)
FIG. 25 Global Clinical Trial Recruitment in Respiratory Market, by Adult (18 – 64 Years), Value, 2016-2028 (US$ Bn
FIG. 26 Global Clinical Trial Recruitment in Respiratory Market, by Older Adults (65 Years+), Value, 2016-2028 (US$ Bn)
FIG. 27 U.S. Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 28 Canada Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 29 Germany Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 30 France Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 31 U.K. Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 32 Italy Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 33 Spain Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 34 Rest of Europe Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 35 China Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 36 Japan Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 37 India Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 38 South Korea Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 39 Southeast Asia Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 40 Rest of Asia Pacific Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 41 Latin America Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 42 Brazil Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 43 Mexico Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 44 Rest of Latin America Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 45 Middle East & Africa Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 46 GCC Countries Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 47 South Africa Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)
FIG. 48 Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Clinical Trial Recruitment in Respiratory Market
TABLE 2 Global Clinical Trial Recruitment in Respiratory Market, by Competitive Benchmarking, 2021
TABLE 3 Global Clinical Trial Recruitment in Respiratory Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Clinical Trial Recruitment in Respiratory Market, by Key Strategies Analysis, 2021
TABLE 5 Global Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 6 Global Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 7 Global Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 8 Global Clinical Trial Recruitment in Respiratory Market, by Geography, 2016-2028 (US$ Bn)
TABLE 9 North America Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 10 North America Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 11 North America Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 12 North America Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
TABLE 13 US Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 14 US Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 15 US Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 16 Canada Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 17 Canada Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 18 Canada Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 19 Europe Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 20 Europe Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 21 Europe Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 22 Europe Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
TABLE 23 Germany Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 24 Germany Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 25 Germany Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 26 France Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 27 France Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 28 France Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 29 UK Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 30 UK Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 31 UK Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 32 Italy Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 33 Italy Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 34 Italy Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 35 Spain Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 36 Spain Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 37 Spain Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 38 Rest of Europe Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 39 Rest of Europe Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 40 Rest of Europe Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 41 Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 42 Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 43 Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 44 Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
TABLE 45 China Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 46 China Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 47 China Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 48 Japan Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 49 Japan Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 50 Japan Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 51 India Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 52 India Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 53 India Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 54 South Korea Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 55 South Korea Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 56 South Korea Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 57 South East Asia Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 58 South East Asia Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 59 South East Asia Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 60 Rest of Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 61 Rest of Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 62 Rest of Asia Pacific Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 63 Latin America Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 64 Latin America Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 65 Latin America Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 66 Latin America Clinical Trial Recruitment in Respiratory Market, by Country, 2016-2028 (US$ Bn)
TABLE 67 Brazil Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 68 Brazil Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 69 Brazil Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 70 Mexico Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 71 Mexico Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 72 Mexico Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 73 Rest of Latin America Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 74 Rest of Latin America Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 75 Rest of Latin America Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 76 Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 77 Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 78 Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 79 GCC Countries Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 80 GCC Countries Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 81 GCC Countries Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 82 South Africa Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 83 South Africa Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 84 South Africa Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)
TABLE 85 Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Service Type, 2016-2028 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Phase, 2016-2028 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Clinical Trial Recruitment in Respiratory Market, by Age Group, 2016-2028 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global clinical trial recruitment in respiratory market?

The COVID-19 outbreak temporarily hampered clinical research progress in 2020, owing to the government’s shutdown, which negatively influenced the market growth.

Which is the leading region of the market for clinical trial recruitment in respiratory?

North America accounted for the major global clinical trial recruitment in respiratory market revenue.

What are the key drivers for the growth of the clinical trial recruitment in respiratory market?

The major drivers responsible for the market’s growth include

Which is the major segment in the clinical trial recruitment in respiratory market by service type?

The patient recruitment & registry services segment had a major share in the global market in 2021.

Which is the major segment in the clinical trial recruitment in respiratory market by phase?

The phase III segment had a major share in the global market in 2021.

Clinical Rollators Market

Published:
Report ID: 35120

Automated Microscopy Market

Published:
Report ID: 35117

Anastomosis Devices Market

Published:
Report ID: 35112

Orthopedic Navigation Systems Market

Published:
Report ID: 35108

Laryngeal Stents Market

Published:
Report ID: 35102

Medical Copper Tubing Market

Published:
Report ID: 35098

Molecular Transport Medium Market

Published:
Report ID: 35092

Neurovascular Thrombectomy Device Market

Published:
Report ID: 35073

Diagnostic Imaging Centers Market

Published:
Report ID: 35050

Electric Stimulation Devices Market

Published:
Report ID: 35047

Angiotensin Converting Enzyme (ACE) Inhibitors Market

Published:
Report ID: 12832

Venipuncture Procedure Market

Published:
Report ID: 34886

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN